The lawsuit expenditure will not have a material impact but...

  1. 1 Posts.
    The lawsuit expenditure will not have a material impact but "Should the relevant patent families for Axiron be found to be invalid, then the result could be the potential launch of generic competition to Axiron in the United States, which would cause a decline in Axiron's net sales and the resulting royalties received by Acrux."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $7.747M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $5.562K 292.7K

Buyers (Bids)

No. Vol. Price($)
4 381825 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 60000 2
View Market Depth
Last trade - 15.04pm 20/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.